Status: Recruiting
Dose Regimen Study of SLI-F06 in Healthy Volunteers
Multi-center, dose-regimen, double-blind study evaluating the safety and efficacy of 4 doses of SLI-F06 compared with vehicle for improvement in scar appearance
Participants needed: 30
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Scarless Laboratories, Inc.Updated: Jul 27, 2023Locations: 2
Eligibility criteria
Healthy subjects, male or female, ages 18 to 65 [+4]
Female subjects who are pregnant, breast-feeding, or of childbearing potential a... [+21]